Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Schally, Andrew V  [Clear All Filters]
2024
Gaumond SI, Abdin R, Costoya J, Schally AV, Jimenez JJ. Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia. Oncotarget. 2024;15:248-254.
2023
Cui T, Wangpaichitr M, Schally AV, Griswold AJ, Vidaurre I, Sha W, Jackson RM. Alveolar epithelial cell growth hormone releasing hormone receptor in alveolar epithelial inflammation. Exp Lung Res. 2023;49(1):152-164.
Kanashiro-Takeuchi RM, Takeuchi LM, Dulce RA, Kazmierczak K, Balkan W, Cai R, Sha W, Schally AV, Hare JM. Efficacy of a Growth Hormone-Releasing Hormone Agonist in a Murine Model of Cardiometabolic Heart Failure with Preserved Ejection Fraction. Am J Physiol Heart Circ Physiol. 2023.
Louzada RA, Blandino-Rosano M, Flores S, Lubaczeuski C, Cui T, Sha W, Cai R, Schally AV, Bernal-Mizrachi E. GRHR agonist MR-409 protects β-cells from streptozotocin-induced diabetes. Proc Natl Acad Sci U S A. 2023;120(25):e2209810120.
Capcha JMCondor, Kamiar A, Robleto E, Saad AG, Cui T, Wong A, Villano J, Zhong W, Pekosz A, Medina E, et al. Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice. Proc Natl Acad Sci U S A. 2023;120(48):e2308342120.
2021
Xiang P, Jing W, Lin Y, Liu Q, Shen J, Hu X, Chen J, Cai R, Hare JM, Zhu W, et al. Improvement of cardiac and systemic function in old mice by agonist of growth hormone-releasing hormone. J Cell Physiol. 2021.
Cai R, Zhang X, Wang H, Cui T, Halmos G, Sha W, He J, Popovics P, Vidaurre I, Zhang C, et al. Synthesis of Potent Antagonists of Receptors for Growth Hormone-Releasing Hormone with High Antitumor and Anti-inflammatory Activity. Peptides. 2021:170716.
2019
Schally AV, Zhang X, Cai R, Hare JM, Granata R, Bartoli M. Actions and potential therapeutic applications of growth hormone-releasing hormone agonists. Endocrinology. 2019.
2016
Cui T, Jimenez JJ, Block NL, Badiavas EV, Rodriguez-Menocal L, Granda AVila, Cai R, Sha W, Zarandi M, Perez R, et al. Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways. Oncotarget. 2016.
2013
Jaszberenyi M, Rick FG, Popovics P, Block NL, Zarandi M, Cai R-Z, Vidaurre I, Szalontay L, Jayakumar AR, Schally AV. Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists. Proc Natl Acad Sci U S A. 2013.